OctoPlus

Dr Reddy’s Laboratories agrees to acquire OctoPlus for €27.39 million

Dr Reddy’s Laboratories agrees to acquire OctoPlus for €27.39 millionHyderabad-based Dr Reddy's Laboratories has confirmed its decision to acquire Netherlands-based specialty pharmaceuticals firm OctoPlus NV for 27.39 million (192 crore) in an all-cash deal.

The offer of 0.52 for each share of OctoPlus represents a premium of 30 per cent to the stock's closing price on the Amsterdam Stock Exchange (ASE) on October 19.

Dr Reddy’s to takeover OctoPlus for 27.4 million euros

Dr Reddy’s to takeover OctoPlus for 27.4 million eurosIndian drug maker, Dr Reddy's Laboratories has announced its decision to acquire OctoPlus NV, a specialty pharmaceutical company based in the Netherlands, for 27.4 million euros.

The two companies said in a joint statement that they have reached a reached conditional agreement over the takeover. Dr Reddy's Laboratories or a wholly owned subsidiary will launch an intended public offer to acquire all issued and outstanding ordinary shares of OctoPlus. Dr Reddy's will acquire the company's shares at the rate of 0.52 euro per share.




Check out More news from Telecom Sector :: Pharmaceutical Sector :: Auto Sector :: Infrastructure :: Real Estate


Syndicate content